Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women

Lead Sponsor:

Dartmouth-Hitchcock Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Cervical Cancer

Eligibility:

FEMALE

40-69 years

Phase:

PHASE2

Brief Summary

RATIONALE: Studying the barriers that prevent minority and low-income women from undergoing cancer screening, and offering encouragement to them over the telephone, may help improve cancer screening r...

Detailed Description

OBJECTIVES: * Determine whether telephone support for patients, provided through a Prevention Care Manager (PCM), can increase breast, cervical, and colorectal cancer screening rates among minority a...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Patients enrolled in the Prevention Care Manager (PCM) controlled, randomized clinical trial (RCT) must meet the following criteria:
  • Registered to receive care at a participating Community Health Center for at least 6 months
  • Overdue for at least one cancer screening as per the following time periods:
  • No mammography within the past 12 months
  • No Pap test within the past 12 months
  • No home fecal occult blood test within the past 12 months
  • No sigmoidoscopy within the past 5 years
  • No colonoscopy within the past 10 years
  • Must not plan to move out of area or change Community Health Center within 15 months
  • No unresolved, urgent abnormal cancer screening result found in medical record
  • Patients enrolled in the PCM dissemination pilot study through Affinity Health Plan must meet the following criteria:
  • Enrolled with Affinity Health Plan for at least 12 months
  • Overdue for at least one cancer screening as per the following time periods:
  • No mammography within the past 2 years
  • No Pap test within the past 3 years
  • No home fecal occult blood test within the past year for women ≥ 50 years old
  • No sigmoidoscopy within the past 5 years
  • No colonoscopy within the past 10 years
  • Must have received care at 1 of 6 participating Community Health Centers in New York City
  • PATIENT CHARACTERISTICS:
  • Female
  • Must not be in acute distress or have an acute illness
  • Age 50 to 69 years for controlled study patients
  • Age 40 to 69 years for pilot study patients
  • PRIOR CONCURRENT THERAPY:
  • No concurrent chemotherapy or radiotherapy
  • No concurrent active cancer treatment
  • No concurrent palliative care

Exclusion

    Key Trial Info

    Start Date :

    November 1 2001

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    2729 Patients enrolled

    Trial Details

    Trial ID

    NCT00376909

    Start Date

    November 1 2001

    Last Update

    December 2 2014

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States, 03756-0002

    2

    Clinical Directors Network, Incorporated

    New York, New York, United States, 10018